Tianeptine, a atypical antidepressant, operates through a novel mechanism compared to typical antidepressants, largely impacting the regulation of serotonin receptors . Initially developed in Europe , it’s now utilized off-label to manage major depressive disorder , particularly when other treatments appear unsatisfactory . However, its expanding